New drug 9MW1911 tested for safety in first human trial
NCT ID NCT05803902
First seen Jan 05, 2026 · Last updated Jun 19, 2026 · Updated 34 times
Summary
This Phase 1 trial tested the safety and tolerability of a new drug called 9MW1911 in 48 healthy adults. Participants received either the drug or a placebo by IV infusion. The study aims to find the maximum safe dose and understand how the drug moves through the body. This is early research for potential treatments of asthma, COPD, and atopic dermatitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Hospital
Beijing, Beijing Municipality, 100000, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
9MW1911 injection
What this could lead to
If successful, this could lead to a new treatment option for asthma, COPD, or atopic dermatitis.
What could go wrong
This is an early Phase 1 trial in healthy people, so it does not test effectiveness. The drug may cause side effects or fail in later studies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.